|
[1]
|
Huang, J., Deng, Y., Boakye, D., et al. (2022) Global Distribution, Risk Factors, and Recent Trends for Cervical Cancer: A Worldwide Country-Level Analysis. Gynecologic Oncology, 164, 85-92. [Google Scholar] [CrossRef] [PubMed]
|
|
[2]
|
Guo, M., Xu, J. and Du, J. (2021) Trends in Cervical Cancer Mortality in China from 1989 to 2018: An Age-Period-Cohort Study and Joinpoint Analysis. BMC Public Health, 21, Article No. 1329. [Google Scholar] [CrossRef] [PubMed]
|
|
[3]
|
Sung, H., Ferlay, J., Siegel, R.L., et al. (2021) Global Cancer Statistics 2020: GLOBOCAN Estimates of Incidence and Mortality Worldwide for 36 Cancers in 185 Countries. CA: A Cancer Journal for Clinicians, 71, 209-249. [Google Scholar] [CrossRef] [PubMed]
|
|
[4]
|
张璐, 隋龙. 中国21~24岁女性宫颈癌筛查现状及应对困扰[J]. 现代妇产科进展, 2021, 30(12): 951-953. http://dx.doi.org/10.13283/j.cnki.xdfckjz.2021.12.043 [Google Scholar] [CrossRef]
|
|
[5]
|
Basu, P., Taghavi, K., Hu, S.Y., et al. (2018) Management of Cervical Premalignant Lesions. Current Problems in Cancer, 42, 129-136. [Google Scholar] [CrossRef] [PubMed]
|
|
[6]
|
Arbyn, M., Weiderpass, E., Bruni, L., et al. (2020) Estimates of Incidence and Mortality of Cervical Cancer in 2018: A Worldwide Analysis. The Lancet Global Health, 8, E191-E203. [Google Scholar] [CrossRef]
|
|
[7]
|
Alfaro, K., Maza, M., Cremer, M., et al. (2021) Removing Global Barriers to Cervical Cancer Prevention and Moving towards Elimination. Nature Reviews Cancer, 21, 607-608. [Google Scholar] [CrossRef] [PubMed]
|
|
[8]
|
陈飞, 胡尚英, 李燕, 等. 中国子宫颈癌综合防控路径建设专家共识[J]. 中国预防医学杂志, 2022, 23(10): 721-726. http://dx.doi.org/10.16506/j.1009-6639.2022.10.001 [Google Scholar] [CrossRef]
|
|
[9]
|
Ntanasis-Stathopoulos, I., Kyriazoglou, A., Liontos, M., et al. (2020) Current Trends in the Management and Prevention of Human Papillomavirus (HPV) Infection. Journal of BUON: Official Journal of the Balkan Union of Oncology, 25, 1281-1285
|
|
[10]
|
Oyouni, A.A.A. (2023) Human Papillomavirus in Cancer: Infection, Disease Transmission, and Progress in Vaccines. Journal of Infection and Public Health, 16, 626-631. [Google Scholar] [CrossRef] [PubMed]
|
|
[11]
|
Mcbride, A.A. (2022) Human Papillomaviruses: Diversity, Infection and Host Interactions. Nature Reviews Microbiology, 20, 95-108. [Google Scholar] [CrossRef] [PubMed]
|
|
[12]
|
Zur Hausen, H. (2002) Papillomaviruses and Cancer: From Basic Studies to Clinical Application. Nature Reviews Cancer, 2, 342-350. [Google Scholar] [CrossRef] [PubMed]
|
|
[13]
|
Hu, Z. and Ma, D. (2018) The Precision Prevention and Therapy of HPV-Related Cervical Cancer: New Concepts and Clinical Implications. Cancer Medicine, 7, 5217-5236. [Google Scholar] [CrossRef] [PubMed]
|
|
[14]
|
Burd, E.M. (2003) Human Papillomavirus and Cervical Cancer. Clinical Microbiology Reviews, 16, 1-17. [Google Scholar] [CrossRef]
|
|
[15]
|
Berti, F.C.B., Salviano-Silva, A., Beckert, H.C., et al. (2019) From Squamous Intraepithelial Lesions to Cervical Cancer: Circulating MicroRNAs as Potential Biomarkers in Cervical Carcinogenesis. Biochimica et Biophysica Acta—Reviews on Cancer, 1872, Article ID: 188306. [Google Scholar] [CrossRef] [PubMed]
|
|
[16]
|
Bhatla, N. and Singhal, S. (2020) Primary HPV Screening for Cervical Cancer. Best Practice & Research Clinical Obstetrics & Gynaecology, 65, 98-108. [Google Scholar] [CrossRef] [PubMed]
|
|
[17]
|
Fontham, E.T.H., Wolf, A.M.D., Church, T.R., et al. (2020) Cervical Cancer Screening for Individuals at Average Risk: 2020 Guideline Update from the American Cancer Society. CA: A Cancer Journal for Clinicians, 70, 321-346. [Google Scholar] [CrossRef] [PubMed]
|
|
[18]
|
Hu, S.Y., Zhao, X.L., Zhang, Y., et al. (2021) [Interpretation of “WHO Guideline for Screening and Treatment of Cervical Pre-Cancer Lesions for Cervical Cancer Prevention, Second Edition”]. Chinese Medical Journal, 101, 2653-2657.
|
|
[19]
|
国家卫生健康委员会. 国家卫生健康委办公厅关于印发宫颈癌筛查工作方案和乳腺癌筛查工作方案的通知(国卫办妇幼函〔2021〕635号) [Z]. 2021.
|
|
[20]
|
李明珠, 魏丽惠, 隋龙, 等. 中国子宫颈癌筛查指南(一) [J]. 中国妇产科临床杂志, 2023, 24(4): 437-442. http://dx.doi.org/10.13390/j.issn.1672-1861.2023.04.029 [Google Scholar] [CrossRef]
|
|
[21]
|
Mremi, A., Mchome, B., Mlay, J., et al. (2022) Performance of HPV Testing, Pap Smear and VIA in Women Attending Cervical Cancer Screening in Kilimanjaro Region, Northern Tanzania: A Cross-Sectional Study Nested in a Cohort. BMJ Open, 12, e064321. [Google Scholar] [CrossRef] [PubMed]
|
|
[22]
|
Kaban, I., Bacanakgil, B.H. and Koca, S. (2021) The Comparison of Two Methods in Cervical Smear Screening—Which Method Is Better for Smear Adequacy Rates? Ginekologia Polska, 92, 335-338. [Google Scholar] [CrossRef]
|
|
[23]
|
Diamantis, A. and Magiorkinis, E. (2014) Pioneers of Exfoliative Cytology in the 19th Century: The Predecessors of George Papanicolaou. Cytopathology, 25, 215-224. [Google Scholar] [CrossRef] [PubMed]
|
|
[24]
|
Papanicolaou, G.N. and Traut, H.F. (1997) The Diagnostic Value of Vaginal Smears in Carcinoma of the Uterus. 1941. Archives of Pathology & Laboratory Medicine, 121, 211-224.
|
|
[25]
|
Zhu, J., Norman, I., Elfgren, K., et al. (2007) A Comparison of Liquid-Based Cytology and Pap Smear as a Screening Method for Cervical Cancer. Oncology Reports, 18, 157-160. [Google Scholar] [CrossRef]
|
|
[26]
|
Khakwani, M., Parveen, R. and Azhar, M. (2022) Comparison of PAP Smear and Liquid Based Cytology as a Screening Method for Cervical Carcinoma. Pakistan Journal of Medical Sciences, 38, 1827-1831. [Google Scholar] [CrossRef] [PubMed]
|
|
[27]
|
Park, I.A., Lee, S.N., Chae, S.W., et al. (2001) Comparing the Accuracy of ThinPrep Pap Tests and Conventional Papanicolaou Smears on the Basis of the Histologic Diagnosis: A Clinical Study of Women with Cervical Abnormalities. Acta Cytologica, 45, 525-531. [Google Scholar] [CrossRef] [PubMed]
|
|
[28]
|
Dighe, S.B., Ajit, D., Pathuthara, S., et al. (2006) Papanicolaou Stain: Is It Economical to Switch to Rapid, Economical, Acetic Acid, Papanicolaou Stain? Acta Cytologica, 50, 643-646. [Google Scholar] [CrossRef] [PubMed]
|
|
[29]
|
Liang, L.A., Einzmann, T., Franzen, A., et al. (2021) Cervical Cancer Screening: Comparison of Conventional Pap Smear Test, Liquid-Based Cytology, and Human Papillomavirus Testing as Stand-Alone or Cotesting Strategies. Cancer Epidemiology, Biomarkers & Prevention, 30, 474-484. [Google Scholar] [CrossRef]
|
|
[30]
|
Siebers, A.G., Klinkhamer, P.J., Grefte, J.M., et al. (2009) Comparison of Liquid-Based Cytology with Conventional Cytology for Detection of Cervical Cancer Precursors: A Randomized Controlled Trial. JAMA, 302, 1757-1764. [Google Scholar] [CrossRef] [PubMed]
|
|
[31]
|
Koliopoulos, G., Nyaga, V.N., Santesso, N., et al. (2017) Cytology versus HPV Testing for Cervical Cancer Screening in the General Population. The Cochrane Database of Systematic Reviews, 8, CD008587. [Google Scholar] [CrossRef]
|
|
[32]
|
Elfström, K.M., Arnheim-Dahlström, L., Von Karsa, L., et al. (2015) Cervical Cancer Screening in Europe: Quality Assurance and Organisation of Programmes. European Journal of Cancer, 51, 950-968. [Google Scholar] [CrossRef] [PubMed]
|
|
[33]
|
Chrysostomou, A.C., Stylianou, D.C., Constantinidou, A. and Kostrikis, L.G. (2018) Cervical Cancer Screening Programs in Europe: The Transition towards HPV Vaccination and Population-Based HPV Testing. Viruses, 10, Article 729. [Google Scholar] [CrossRef] [PubMed]
|
|
[34]
|
Rozemeijer, K., Penning, C., Siebers, A.G., et al. (2016) Comparing SurePath, ThinPrep, and Conventional Cytology as Primary Test Method: SurePath Is Associated with Increased CIN II Detection Rates. Cancer Causes & Control, 27, 15-25. [Google Scholar] [CrossRef] [PubMed]
|
|
[35]
|
Zhao, F.H., Hu, S.Y., Bian, J.J., et al. (2011) Comparison of ThinPrep and SurePath Liquid-Based Cytology and Subsequent Human Papillomavirus DNA Testing in China. Cancer Cytopathology, 119, 387-394. [Google Scholar] [CrossRef] [PubMed]
|
|
[36]
|
李琪. 液基细胞学、阴道镜组织活检和HPV-DNA检测防治宫颈癌前病变的价值研究[J]. 中国妇幼保健, 2018, 33(15): 3578-3580.
|
|
[37]
|
Taylor, S., Kuhn, L., Dupree, W., et al. (2006) Direct Comparison of Liquid-Based and Conventional Cytology in a South African Screening Trial. International Journal of Cancer, 118, 957-962. [Google Scholar] [CrossRef] [PubMed]
|
|
[38]
|
Patel, N., Bavikar, R., Buch, A., et al. (2023) A Comparison of Conventional Pap Smear and Liquid-Based Cytology for Cervical Cancer Screening. Gynecology and Minimally Invasive Therapy, 12, 77-82. [Google Scholar] [CrossRef] [PubMed]
|
|
[39]
|
Davey, E., D’assuncao, J., Irwig, L., et al. (2007) Accuracy of Reading Liquid Based Cytology Slides Using the ThinPrep Imager Compared with Conventional Cytology: Prospective Study. BMJ, 335, 31. [Google Scholar] [CrossRef] [PubMed]
|
|
[40]
|
续薇. 临床细胞病理学诊断报告新方法——TBS诊断标准及要点[J]. 中国实验诊断学, 1999, 3(5): 2.
|
|
[41]
|
Pangarkar, M.A. (2022) The Bethesda System for Reporting Cervical Cytology. Cyto Journal, 19, Article 28. [Google Scholar] [CrossRef]
|
|
[42]
|
Zhao, C., Crothers, B.A., Tabatabai, Z.L., et al. (2017) False-Negative Interpretation of Adenocarcinoma in Situ in the College of American Pathologists Gynecologic PAP Education Program. Archives of Pathology & Laboratory Medicine, 141, 666-670. [Google Scholar] [CrossRef]
|
|
[43]
|
Clarke, M.A., Cheung, L.C., Castle, P.E., et al. (2019) Five-Year Risk of Cervical Precancer Following P16/Ki-67 Dual-Stain Triage of HPV-Positive Women. JAMA Oncology, 5, 181-186. [Google Scholar] [CrossRef] [PubMed]
|
|
[44]
|
Cooper, D.B. and Dunton, C.J. (2023) Colposcopy. StatPearls, Treasure Island.
|
|
[45]
|
Khan, M.J., Werner, C.L., Darragh, T.M., et al. (2017) ASCCP Colposcopy Standards: Role of Colposcopy, Benefits, Potential Harms, and Terminology for Colposcopic Practice. Journal of Lower Genital Tract Disease, 21, 223-229. [Google Scholar] [CrossRef]
|
|
[46]
|
Grigore, M., Cruickshank, M.E., Nieminen, P., et al. (2021) National Guidelines for Management of Cervical Squamous Intraepithelial Lesion: A Survey of European Federation for Colposcopy Members. European Journal of Obstetrics, Gynecology, and Reproductive Biology, 256, 46-50. [Google Scholar] [CrossRef] [PubMed]
|
|
[47]
|
彭汝娇, 刘姜伶, 郑诗丹, 等. 阴道镜检查与宫颈电环锥切术在宫颈病变诊治中的应用[J]. 现代妇产科进展, 2016, 25(4): 298-301. http://dx.doi.org/10.13283/j.cnki.xdfckjz.2016.04.015 [Google Scholar] [CrossRef]
|
|
[48]
|
陈哲, 刘文静, 王涛. 阴道镜用于筛查宫颈癌前病变的价值研究[J]. 中国实用医药, 2022, 17(15): 92-94. http://dx.doi.org/10.14163/j.cnki.11-5547/r.2022.15.028 [Google Scholar] [CrossRef]
|
|
[49]
|
Egemen, D., Cheung, L.C., Chen, X., et al. (2020) Risk Estimates Supporting the 2019 ASCCP Risk-Based Management Consensus Guidelines. Journal of Lower Genital Tract Disease, 24, 132-143. [Google Scholar] [CrossRef]
|
|
[50]
|
赵超, 毕蕙, 赵昀, 等. 子宫颈高级别上皮内病变管理的中国专家共识[J]. 中国妇产科临床杂志, 2022, 23(2): 220-224. http://dx.doi.org/10.13390/j.issn.1672-1861.2022.02.038 [Google Scholar] [CrossRef]
|
|
[51]
|
王红, 徐福智, 赵秋艳. 三阶梯诊疗程序筛查宫颈癌前病变[J]. 中国妇幼保健, 2011, 26(5): 769-770.
|
|
[52]
|
Fatahi Meybodi, N., Karimi-Zarchi, M., Allahqoli, L., et al. (2020) Accuracy of the Triple Test Versus Colposcopy for the Diagnosis of Premalignant and Malignant Cervical Lesions. Asian Pacific Journal of Cancer Prevention, 21, 3501-3507. [Google Scholar] [CrossRef]
|
|
[53]
|
Perkins, R.B., Guido, R.S., Castle, P.E., et al. (2020) 2019 ASCCP Risk-Based Management Consensus Guidelines for Abnormal Cervical Cancer Screening Tests and Cancer Precursors. Journal of Lower Genital Tract Disease, 24, 102-131. [Google Scholar] [CrossRef]
|
|
[54]
|
李军英, 冯相珍. 宫颈上皮内瘤变患者宫颈锥切术后病变残留和复发的列线图预测模型构建与评估[J]. 实用癌症杂志, 2023, 38(5): 834-838.
|
|
[55]
|
Soutter, W.P., Sasieni, P. and Panoskaltsis, T. (2006) Long-Term Risk of Invasive Cervical Cancer after Treatment of Squamous Cervical Intraepithelial Neoplasia. International Journal of Cancer, 118, 2048-2055. [Google Scholar] [CrossRef] [PubMed]
|